Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.61) by 18.03 percent. This is a 13.64 percent decrease over losses of $(0.44) per share from the same period last year.
Guggenheim Maintains Buy on Merus, Raises Price Target to $46
Guggenheim analyst Charles Zhu maintains Merus (NASDAQ:MRUS) with a Buy and raises the price target from $44 to $46.
